24/7 Market News Snapshot 20 October, 2025 – SciSparc Ltd. Ordinary Shares (NASDAQ:SPRC)

October 20, 2025

DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (Nasdaq:SPRC) are discussed in this article.
SciSparc Ltd. (Nasdaq:SPRC) is currently demonstrating a strong upward trajectory in the pre-market, trading at $4.216, which represents a significant increase of 10.37% from the prior close of $3.820. With a trading volume of 1.47 million shares, investor enthusiasm appears robust, suggesting a ripe environment for further price action. Analysts are advised to keep a close watch on key support and resistance levels, particularly around the $4.20 line, as this may influence entry points for potential investors. The noticeable buying pressure indicates that SciSparc may be well-positioned for sustained growth in the near term.

In an exciting development, SciSparc has announced the publication of a U.S. patent application arising from its collaboration with Clearmind Medicine Inc. This application pertains to an innovative combination therapy that utilizes MEAI (5-methoxy-2-aminoindane) alongside N-Acylethanolamines, including Palmitoylethanolamide (PEA). The targeted therapy aims to address various binge behavior disorders, such as excessive alcohol consumption, eating disorders, and cocaine addiction.

Leveraging the psychedelic attributes of MEAI to diminish impulsivity, while incorporating the anti-inflammatory advantages of PEA, this groundbreaking approach holds the potential to revolutionize the management of substance use and behavioral conditions. Preclinical results indicate that this therapy could effectively reduce binge episodes while protecting essential natural reward pathways, presenting a significant improvement over existing treatment modalities.

SciSparc’s ongoing focus on innovative research and development underscores its dedication to tackling some of the most challenging health issues. This latest patent application marks an important milestone for the company, suggesting promising opportunities for clinical applications in the future.

Related news for (SPRC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.